Live Breaking News & Updates on Golimumab

Stay updated with breaking news from Golimumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Alvotech Announces Positive Topline Results From Confirmatory Clinical Study For Its Proposed Golimumab Biosimilar - Life Sciences, Biotechnology & Nanotechnology

On April 23, 2024, Alvotech announced "positive topline results from a confirmatory clinical study for AVT05," Alvotech's proposed golimumab biosimilar to Janssen Biotech, Inc.'s. ....

United States , Foley Lardner , Sarah Hogan , Stephen Page , Gina Bertolini , Sheppard Mullin Richter Hampton , Columbus Regional Healthcare System Inc , California Office Of Health Care Affordability , Us Department Of Justice , Health Care , Subcommittee On Primary Health , American Health Law Association , Life Sciences , Akin Gump Strauss Hauer Feld , Senate Health , Human Service Office , Inspector General , Health Care Contracts , Clause By Guide , Sarah Staples Carlton , Health Care Affordability , Regional Healthcare System , Senators Edward Markey , Elizabeth Warren , Primary Health , Retirement Security ,

Novel and emerging therapies offer new hope for patients with inflammatory bowel disease

Ulcerative colitis (UC) and Crohn's disease (CD) are chronic inflammatory bowel diseases (IBD) that affect the gastrointestinal tract. ....

Lily Ramsey , International Organisation , Inflammatory Bowel Diseases , Selecting Therapeutic Targets , Inflammatory Bowel Disease , Cell Adhesion , Ulcerative Colitis ,

Alvotech, Advanz Pharma Extend Partnership for Biosimilars in Europe

Alvotech and Advanz Pharma extend their partnership to commercialize 5 biosimilar candidates across Europe. ....

United Kingdom , New Zealand , Advanz Pharma , Robert Wessman , Iceland Based Alvotech , European Economic Area , Anil Okay , Advanz Pharma ,

Biosimilars Business News Recap: A New Partnership; Celltrion Wins Tenders

As Sandoz and Just-Evotec Biologics announce a new partnership, Celltrion secures tender wins in Italy and Belgium, and Alvotech begins testing its golimumab biosimilar in patients with rheumatoid arthritis. ....

Emilia Romagna , Region Flamande , South Korea , Joseph Mcclellan , Evotec Biologics , Richard Saynor , Evotec Biologics Partnership , Brugge Regional Hospital Group , Just Evotec Biologics , Just Evotec Biologic , Korea Biomedical , Onze Lieve Vrouw General , Yoo Won Sik , Celltrion Healthcare Italy , Simponi Aria , Celltrion Healthcare ,

Study Finds Combination Therapy Does Little to Slow Spine Damage in Radiographic Axial Spondyloarthritis Patients

ATLANTA New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that combining a nonsteroidal anti-inflammatory drug and TNF inhibitor did not significantly slow radiographic spinal progression in radiographic axial spondyloarthritis patients ( Abstract #0546 ) ....

New York , United States , German Federal Ministry Of Education , American College Of Rheumatology , American College , Fabian Proft , Stoke Ankylosing Spondylitis Spine Score , German Federal Ministry , Autoimmune Diseases , Back Pain , Medical Specialties , Ankylosing Spondylitis , Axial Spondyloarthritis , Clinical Medicine , Disease Modifying Antirheumatic Drug , Nonsteroidal Anti Inflammatory Drugs ,